-
Continuous algorithmic insights into PD motor symptoms and individual treatment response
-
Continuous estimation of Parkinson’s on-off states using wearable devices
-
Continuous subcutaneous foslevodopa/foscarbidopa: final results from a phase 3, open-label study
-
Continuous subcutaneous levodopa/carbidopa infusion with ND0612 for Parkinson’s disease: Three-year data from the open-label BeyoND study
-
Continuous subcutaneous levodopa/carbidopa infusion with ND0612 for patients with Parkinson’s disease and motor fluctuations: Results from the Phase 3 randomized, active-controlled BouNDless study
-
Contribution of MRI and machine learning approaches to the diagnosis of patients with early-stage parkinsonism in a situation of clinical uncertainty
-
Controlled-release zolpidem improves freezing of gait and levodopa-induced dyskinesias in a patient with Parkinson’s disease.
-
Conventional anti-epileptic drugs used in North Sea Progressive Myoclonus Epilepsy revisited in a Drosophila model
-
Coping strategies in people with Parkinson disease (PwP)
-
COPS: Continuous Observation of Parkinsonian Symptoms – A prospective data acquisition study using wearable accelerometery
- « Previous Page
- 1
- …
- 42
- 43
- 44
- 45
- 46
- …
- 186
- Next Page »